![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI-AVENTIS (FRANCE) AND BRISTOL-MYERS SQUIBB COMPANY RELEASE: PRELIMINARY INJUNCTION ORDERED IN PLAVIX PATENT INFRINGEMENT CASE
SANOFI-AVENTIS (FRANCE) AND BRISTOL-MYERS SQUIBB COMPANY RELEASE: PRELIMINARY INJUNCTION ORDERED IN PLAVIX PATENT INFRINGEMENT CASE
Sanofi-aventis and Bristol-Myers Squibb (the "companies") today announced that the U.S. District Court for the Southern District of New York has granted a preliminary injunction ordering Apotex Inc. and Apotex Corp. ("Apotex") to halt its sales of a generic version of clopidogrel bisulfate product that competes with PLAVIX. The court,
however, did not order Apotex to recall products already sold/shipped.
BioSpace
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct